A Non-Interventional Trial of Xeloda in Metastatic Colorectal Cancer, Adjuvant Colon Cancer, Advanced Gastric Cancer and Breast Cancer

Trial Profile

A Non-Interventional Trial of Xeloda in Metastatic Colorectal Cancer, Adjuvant Colon Cancer, Advanced Gastric Cancer and Breast Cancer

Completed
Phase of Trial: Phase IV

Latest Information Update: 05 May 2016

At a glance

  • Drugs Capecitabine (Primary)
  • Indications Advanced breast cancer; Colon cancer; Colorectal cancer; Gastric cancer
  • Focus Therapeutic Use
  • Sponsors Roche
  • Most Recent Events

    • 29 Mar 2016 Time frame for primary endpoint routine clinical use changed from approximately 2 years to approximately 3 years.
    • 23 May 2013 Actual initiation date changed from Dec 2012 to Jul 2012 as reported by ClinicalTrials.gov.
    • 11 Feb 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top